AI and pancreatic cancer detection: 4 notes
As healthcare leaders celebrate the FDA’s approval of daraxonrasib — a pancreatic cancer drug that nearly doubled survival in clinical trials — two harsh realities remain: most pancreatic cancer patients are still diagnosed at a late stage, and those treated with daraxonrasib will eventually develop resistance to it. Pancreatic cancer is the third-leading cause of […] The post AI and pancreatic cancer detection: 4 notes appeared first on Becker's Hospital Review | Healthcare New...
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.